Dupilumab Improves Itch and Disease Activity in Chronic Spontaneous Urticaria Regardless of BMI, Gender: Study
USA: A study published in The Journal of Allergy and Clinical Immunology reports that Dupilumab significantly reduced itch severity and disease activity in patients with Chronic Spontaneous Urticaria (CSU), with…